Lemtrada
For more than a year, the monoclonal antibody Lemtrada® (Alemtuzumab) has been approved in Germany for the treatment of relapsing MS. Although the study data indicates it is a very effective MS therapy, the drug
Continue reading
Category: Therapy for MS
MS Therapy 2015 – Expectations and Possibilities
Our opportunities in MS therapy have changed and improved significantly over the last 20 years. In the 90s of the last century, the goal of administering MS drugs was to delay the natural course of
Continue reading
Therapy Goals
The 32-year-old engineer was diagnosed with MS at the age of 25. From my perspective, everything initially went quite smoothly: The diagnosis was made directly after the first event and an immunotherapy was initiated. Back
Continue reading
